242 related articles for article (PubMed ID: 12647301)
21. ACE inhibition reduces activity of the plasminogen/plasmin and MMP systems in the brain of spontaneous hypertensive stroke-prone rats.
Liebetrau M; Burggraf D; Wunderlich N; Jäger G; Linz W; Hamann GF
Neurosci Lett; 2005 Mar; 376(3):205-9. PubMed ID: 15721222
[TBL] [Abstract][Full Text] [Related]
22. Plasmin-induced proteolysis of tenascin-C: modulation by T lymphocyte-derived urokinase-type plasminogen activator and effect on T lymphocyte adhesion, activation, and cell clustering.
Gundersen D; Trân-Thang C; Sordat B; Mourali F; Rüegg C
J Immunol; 1997 Feb; 158(3):1051-60. PubMed ID: 9013942
[TBL] [Abstract][Full Text] [Related]
23. Degradation of extracellular matrix by metastatic follicular thyroid carcinoma cell lines: role of the plasmin activation system.
Smit JW; van der Pluijm G; Romijn HA; Löwik CW; Morreau H; Goslings BM
Thyroid; 1999 Sep; 9(9):913-9. PubMed ID: 10524570
[TBL] [Abstract][Full Text] [Related]
24. The plasmin system in airway remodeling.
Kucharewicz I; Kowal K; Buczko W; Bodzenta-Łukaszyk A
Thromb Res; 2003; 112(1-2):1-7. PubMed ID: 15013265
[TBL] [Abstract][Full Text] [Related]
25. [Effects of tissue inhibitor of matrix metalloproteinases-4 on the activities of matrix metalloproteinases and collagen of artery: experiment with rats].
Zu LY; Guo YH; Chen L; Li Q; Yan H; Gao W
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(7):472-5. PubMed ID: 16677575
[TBL] [Abstract][Full Text] [Related]
26. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.
Augé N; Maupas-Schwalm F; Elbaz M; Thiers JC; Waysbort A; Itohara S; Krell HW; Salvayre R; Nègre-Salvayre A
Circulation; 2004 Aug; 110(5):571-8. PubMed ID: 15277330
[TBL] [Abstract][Full Text] [Related]
27. [Effect of frequency of cyclic tensile strain on extracellular matrix of rat vascular smooth muscle cells in vitro].
Qu M; Liu B; Jiang Z
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Aug; 25(4):826-30. PubMed ID: 18788289
[TBL] [Abstract][Full Text] [Related]
28. EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. Implications for plaque rupture.
Schmidt R; Redecke V; Breitfeld Y; Wantia N; Miethke T; Massberg S; Fischel S; Neumann FJ; Schömig A; May AE
Thromb Haemost; 2006 Jan; 95(1):151-8. PubMed ID: 16543974
[TBL] [Abstract][Full Text] [Related]
29. Plasmin induces degradation and dysfunction of laminin 332 (laminin 5) and impaired assembly of basement membrane at the dermal-epidermal junction.
Ogura Y; Matsunaga Y; Nishiyama T; Amano S
Br J Dermatol; 2008 Jul; 159(1):49-60. PubMed ID: 18460030
[TBL] [Abstract][Full Text] [Related]
30. Plasminogen and matrix metalloproteinase activation by enzymatically modified low density lipoproteins in monocytes and smooth muscle cells.
May AE; Schmidt R; Bülbül BO; Hölderle M; Walther F; Schömig A; Gawaz M; Klouche M
Thromb Haemost; 2005 Apr; 93(4):710-5. PubMed ID: 15841317
[TBL] [Abstract][Full Text] [Related]
31. Effect of hormones on matrix metalloproteinases gene regulation in human aortic smooth muscle cells.
Grandas OH; Mountain DJ; Kirkpatrick SS; Rudrapatna VS; Cassada DC; Stevens SL; Freeman MB; Goldman MH
J Surg Res; 2008 Jul; 148(1):94-9. PubMed ID: 18570937
[TBL] [Abstract][Full Text] [Related]
32. High glucose enhance expression of matrix metalloproteinase-2 in smooth muscle cells.
Hao F; Yu JD
Acta Pharmacol Sin; 2003 Jun; 24(6):534-8. PubMed ID: 12791179
[TBL] [Abstract][Full Text] [Related]
33. Fibroblast extracellular matrix gene expression in response to keratinocyte-releasable stratifin.
Ghaffari A; Li Y; Karami A; Ghaffari M; Tredget EE; Ghahary A
J Cell Biochem; 2006 May; 98(2):383-93. PubMed ID: 16440305
[TBL] [Abstract][Full Text] [Related]
34. YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole] inhibits neointima formation in balloon-injured rat carotid through suppression of expressions and activities of matrix metalloproteinases 2 and 9.
Liu YN; Pan SL; Peng CY; Guh JH; Huang DM; Chang YL; Lin CH; Pai HC; Kuo SC; Lee FY; Teng CM
J Pharmacol Exp Ther; 2006 Jan; 316(1):35-41. PubMed ID: 16183705
[TBL] [Abstract][Full Text] [Related]
35. The effect of IL-1alpha on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in osteoblastic ROS 17/2.8 cells.
Fujisaki K; Tanabe N; Suzuki N; Mitsui N; Oka H; Ito K; Maeno M
Life Sci; 2006 Mar; 78(17):1975-82. PubMed ID: 16313928
[TBL] [Abstract][Full Text] [Related]
36. [Matrix metalloproteinases MMP-2 and MMP-9 of wound and burn exudates and their effect on extracellular matrix proteins].
Voronkina IV; Kokorin KV; Chulikov OV; Paramonov BA; Blinova MI; Pinaev GP
Tsitologiia; 2003; 45(1):43-50. PubMed ID: 12683235
[TBL] [Abstract][Full Text] [Related]
37. Membrane-type 1 matrix metalloproteinase modulates focal adhesion stability and cell migration.
Takino T; Watanabe Y; Matsui M; Miyamori H; Kudo T; Seiki M; Sato H
Exp Cell Res; 2006 May; 312(8):1381-9. PubMed ID: 16473349
[TBL] [Abstract][Full Text] [Related]
38. Physiological mechanisms for metalloproteinase activation.
Murphy G; Ward R; Gavrilovic J; Atkinson S
Matrix Suppl; 1992; 1():224-30. PubMed ID: 1480031
[TBL] [Abstract][Full Text] [Related]
39. Matrikines in the regulation of extracellular matrix degradation.
Maquart FX; Bellon G; Pasco S; Monboisse JC
Biochimie; 2005; 87(3-4):353-60. PubMed ID: 15781322
[TBL] [Abstract][Full Text] [Related]
40. The angiotensin-calcineurin-NFAT pathway mediates stretch-induced up-regulation of matrix metalloproteinases-2/-9 in atrial myocytes.
Saygili E; Rana OR; Meyer C; Gemein C; Andrzejewski MG; Ludwig A; Weber C; Schotten U; Krüttgen A; Weis J; Schwinger RH; Mischke K; Rassaf T; Kelm M; Schauerte P
Basic Res Cardiol; 2009 Jul; 104(4):435-48. PubMed ID: 19148693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
